Skip to main content
. Author manuscript; available in PMC: 2023 Feb 2.
Published in final edited form as: Clin Cancer Res. 2022 Aug 2;28(15):3296–3307. doi: 10.1158/1078-0432.CCR-21-4165

Figure 1.

Figure 1.

Frequency (%) of the wild type gene variant reported as a result of the clinical NGS panel of the primary pancreatic ductal adenocarcinoma in a registry cohort. Specimen type (biopsy or resection) was not significantly associated with the frequency of the wild type gene reported (A), whereas the wild type findings were more commonly reported after pretreatment by chemo- (B) or radiotherapy (C), and good response to pretreatment in the surgical pathology report (D).